Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF APRIL 02, 2022 SAM #7428
SOURCES SOUGHT

65 -- Sources Sought Notice � Cost-Per-Test- Immunoassay Testing

Notice Date
3/31/2022 9:39:39 AM
 
Notice Type
Sources Sought
 
NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
 
Contracting Office
W40M USA HLTH CONTRACTING ACT JBSA FT SAM HOUSTON TX 78234-0000 USA
 
ZIP Code
78234-0000
 
Solicitation Number
W81K00-22-Q-0069
 
Response Due
4/7/2022 2:00:00 PM
 
Point of Contact
Medina L. Woodson, Phone: 2105398525, Fax: 2102213446, Randall P. Cummins, Phone: 7195265329, Fax: 7195245405
 
E-Mail Address
medina.l.woodson.civ@mail.mil, randall.p.cummins.civ@mail.mil
(medina.l.woodson.civ@mail.mil, randall.p.cummins.civ@mail.mil)
 
Description
The Regional Health Contracting Office - Central is issuing this Sources Sought Notice on behalf of San Antonio Military Medical Center, JBSA - Fort Sam Houston, Texas. Any responses to this Sources Sought Notice will be used for planning purposes only. This notice is not a solicitation of binding offers, nor is it a notice to proceed. The San Antonio Military Medical Center (SAMMC) has a requirement for three types of immunoassay testing: Hepatitis Antibodies and Antigens assay, anti-thyroglobulin and anti-thyroid peroxidase assay and tacrolimus assay for FY22 through FY26.�� The chemiluminescent micro particle immunoassay provides the quantitative determination of (1) hepatic virus�s antibodies and antigens, (2) antibodies to Thyroglobulin and Thyroid Peroxidase, (3) tacrolimus. The assay results of hepatic virus�s antibodies and antigens, in conjunction with other laboratory results and clinical information, are to aid in the diagnosis of acute, chronic, or resolved hepatitis. The thyroglobulin and thyroid peroxidase testing is to be used as an aid in the diagnosis of autoimmune thyroid disease. The tacrolimus testing is used as aid in management of liver and kidney allograft patients receiving tacrolimus therapy. Vendors that consider themselves capable of providing the required testing are invited to submit a capability statement for the Government to consider via email to the Point of Contact listed herein by 4:00 PM CST on Thursday, 7 April 2022.�
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/c27a840b951641249de478519bcc7ea7/view)
 
Place of Performance
Address: JBSA Ft Sam Houston, TX 78234, USA
Zip Code: 78234
Country: USA
 
Record
SN06286881-F 20220402/220331230115 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.